Morphine sulfate attenuates hemorrhagic shock-induced hyperpermeability

Anesthesia and Analgesia

Volumn 103, Issue 1, 2006, Pages 156-161

  Charleston, Craig ^a   Puana, Rudolph ^a   McAllister, Russell K ^a   Hunter, Felicia A ^a   Childs, Ed W ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HEMORRHAGIC SHOCK; HISTAMINE RELEASE; LEUKOCYTE ADHERENCE; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL PATIENT; VASCULAR ENDOTHELIUM;

EID: 33745830184     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000221186.64599.78     Document Type: Article

References (34)

1. Wood JG, Mattioli LF, Gonzalez NC. Hypoxia causes leukocyte adherence to mesenteric venules in nonacclimatized, but not in acclimatized, rats. J Appl Physiol 1999;87:873-81.
2. Kuwahira I, Gonzalez NC, Heisler N, Piiper J. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J Appl Physiol 1993;74:211-4.
3. Welters ID, Menzebach A, Goumon Y, et al. Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 2000;92:1677-84.
4. Al-Naemi H, Baldwin AL. Nitric oxide: role in venular permeability recovery after histamine challenge. Am J Physiol 1999;277:2010-6.
5. Hermens JM, Ebertzs JM, Hanifin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. Anesthesiology 1985;62:124-9.
6. Ebertz JM, Hermens JM, McMillan JC, et al. Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release. Agents Actions 1986;18:455-62.
7. Tharp MD, Kagey-Sobotka A, Fox CC, et al. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 1987;79:646-53.
8. Fox J, Galey F, Wayland H. Action of histamine on the mesenteric microvasculature. Microvasc Res 1980;19:108-26.
9. Horan KL, Adamski SW, Ayele W, et al. Evidence that prolonged histamine suffusions produce transient increases in vascular permeability subsequent to the formation of venular macromolecular leakage sites: proof of the Majno-Palade hypothesis. Am J Pathol 1986;123:570-6.
10. Wu NZ, Baldwin AL. Transient venular permeability increase and endothelial gap formation induced by histamine. Am J Physiol 1992;262:H1238-47.
11. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-79.
12. Coussons-Read ME, Giese S. Acute morphine treatment alters cellular immune function in the lungs of healthy rats. Int Immunopharmacol 2001;1:1571-81.
13. Chen Y, Liu J, Yu L. Functional coupling of a mu opioid receptor to G proteins and adenylyl cyclase: modulation by chronic morphine treatment. Addict Biol 1996;1:49-59.
14. Wang J, Charboneau R, Barke RA, et al. Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J Immunol 2002;169:3630-6.
15. Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000;90:1411-4.
16. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998;83:36-44.
17. Nishikori T, Irie K, Suganuma T, et al. Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation. Eur J Pharmacol 2002;451:327-33.
18. Bryant HU, Holaday JW. Opioids in immunologic processes. In: Herz A, ed. Opioids II: handbook of experimental pharmacology. Vol. 104/11. Berlin: Springer-Verlag, 1993:361-92.
19. Gaveriaux-Ruff C, Filliol D, Simonin F, et al. Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a non-opioid activity. J Pharmacol Exp Ther 2001;298:1193-8.
20. Grimm MC, Ben-Baruch A, Taub DD, et al. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 1998;188:317-25.
21. Shavit Y, Depaulis A, Martin FC, et al. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci USA 1986;83:7114-7.
22. Babul N, Provencher L, Laberge F, et al. Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain. J Clin Pharmacol 1998;38:74-81.
23. Bekker AY, Ritter AB, Duran WN. Analysis of microvascular permeability to macromolecules by video-image digital processing. Microvasc Res 1989;38:200-16.
24. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats. J Appl Physiol 2000;89:1561-8.
25. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55:662-75.
26. Kubes P, Ibbotson G, Russell J, et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 1990;259:G300-5.
27. Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991;87:1798-804.
28. Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J Immunol 1994;152:3570-7.
29. Campochiaro PA. Ocular neovascularisation and excessive vascular permeability. Expert Opin Biol Ther 2004;4:1395-402.
30. Waisman D, Brod V, Wolff R, et al. Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003;285:H643-52.
31. Rahim RT, Meissler JJ Jr., Cowan A, et al. Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. Int Immunopharmacol 2001;1:2001-9.
32. He P, Zeng M, Curry FE. Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol Heart Circ Physiol 2000;278:H1124-33.
33. Berkow R. Myocardial infarction. In: The Merck manual of diagnosis and therapy. Whitehouse Station, NJ: Merck Research Laboratories Division of Merck & Co., Inc., Copyright © 2003, 2004:section 16, chapter 202.
34. Abrahm JL. Management of pain and spinal cord compression in patients with advanced cancer: ACP-ASIM End-of-life Care Consensus Panel-Am College of Physicians-Am Society of Internal Med. Ann Intern Med 1999;131:37-46.